Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
. This position is part of a translational cell therapy program focused on advancing next-generation immunotherapies from discovery through IND-enabling studies and clinical translation. The successful candidate
-
Location SAINT LOUIS, MO 63110 Scheduled Hours 40 Position Summary The Jimenez laboratory focuses on understanding immunotherapy effects on the heart. The lab uses mice and surgical modeling tools
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 2 months ago
of self-tolerance to the insulin producing beta cells, and 2) Development of immunotherapies for T1D. The work makes use of several genetically manipulated mouse models of T1D, as well as humanized mouse
-
undergoing hematopoietic stem cell transplant (bone marrow, peripheral or cord blood transplant) and immunotherapy. The unit also has a 6 bed clinic to handle outpatient symptom management and outpatient
-
complex cranial neurosurgery and neuro-oncology. Candidates with an additional Ph.D. degree in biology related fields and specific focus of interest in immunotherapy and brain tumors are preferred
-
, transplantation models, or advanced immunological techniques. Experience with vaccine development, immunotherapy, or translational immunology. Interest in translational research related to hematologic disorders
-
immunology research, contributing to projects that explore immune system responses to cancer and developing new immunotherapies for preclinical testing. Reporting to the Postdoctoral Fellow in the Allergy and
-
, focusing on mechanisms of human T cell differentiation and cellular immunotherapy. The ideal applicant will have strong quantitative skills and the ability to work independently (in a see-one, do-one, teach
-
challenges, and providing allergen immunotherapy. These services will be performed at the main campus of Children’s Hospital Colorado and at a Network of Care location. The candidate will participate in 6-12
-
approaches to immunotherapies. The focus of the ICCVS is the development of personalized vaccine against non-small cell lung cancer (NSCLC). The approach is based on use of cancer specific T cells